Medicines Regulation in Africa: Current State and Opportunities.

about

Medicines Regulation in Africa: Current State and Opportunities.

Item

http://www.wikidata.org/entity/Q47142232

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Medicines Regulation in Africa: Current State and Opportunities.

@en

Medicines Regulation in Africa: Current State and Opportunities.

@nl

type

Item

label

Medicines Regulation in Africa: Current State and Opportunities.

@en

Medicines Regulation in Africa: Current State and Opportunities.

@nl

prefLabel

Medicines Regulation in Africa: Current State and Opportunities.

@en

Medicines Regulation in Africa: Current State and Opportunities.

@nl

P1476

Medicines Regulation in Africa: Current State and Opportunities

@en

P2093

Alexander Dodoo

http://www.w3.org/2001/XMLSchema#string

Margareth Ndomondo-Sigonda

http://www.w3.org/2001/XMLSchema#string

Shan Naidoo

http://www.w3.org/2001/XMLSchema#string

P2860

Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature

Challenges and Opportunities While Developing a Group A Meningococcal Conjugate Vaccine Within a Product Development Partnership: A Manufacturer's Perspective From the Serum Institute of India

Regulatory Pathways That Facilitated Timely Registration of a New Group A Meningococcal Conjugate Vaccine for Africa's Meningitis Belt Countries

Responding to the pandemic of falsified medicines.

EDCTP regional networks of excellence: initial merits for planned clinical trials in Africa.

Strengthening medical product regulation in low- and middle-income countries

Registering new drugs for low-income countries: the African challenge.

Specific features of medicines safety and pharmacovigilance in Africa

Drugs for neglected diseases: a failure of the market and a public health failure?

Post-marketing surveillance of anti-malarial medicines used in Malawi.

P2888

s40290-017-0210-x

P304

383-397

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40290-017-0210-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jacqui Miot

Eliangiringa Kaale

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29200865

http://www.w3.org/2001/XMLSchema#string

P932

5691122

http://www.w3.org/2001/XMLSchema#string